Lin Jiang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 6
- Congenital heart defects research 4
- Cell death mechanisms and regulation 4
-
- Cancer-related molecular mechanisms research 12
- Co-authors
- Yingbin Liu (17 shared papers)Yunping Hu (15 shared papers)Yuliang Feng (3 shared papers)Xiangsong Wu (9 shared papers)Maolan Li (9 shared papers)Honghong Tan (2 shared papers)Yang Cao (8 shared papers)Xiaojun Yang (1 shared paper)
- Journals
- Nucleic Acids Research (3 papers)Experimental Biology and Medicine (2 papers)Cell Death and Disease (2 papers)Cancer Cell International (2 papers)Molecular Cancer (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lin Jiang
53 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 788
- Molecular Biology 1.4k
- Oncology 235
- Toxicology 27
- Surgery 313
Countries citing papers authored by Lin Jiang
This map shows the geographic impact of Lin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jiang more than expected).
Fields of papers citing papers by Lin Jiang
This network shows the impact of papers produced by Lin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jiang. The network helps show where Lin Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 306 | |
| 2 | 2014 | 199 | |
| 3 | 2020 | 194 | |
| 4 | 2019 | 141 | |
| 5 | 2018 | 130 | |
| 6 | 2014 | 77 | |
| 7 | 2013 | 65 | |
| 8 | 2017 | 56 | |
| 9 | 2011 | 55 | |
| 10 | 2014 | 50 | |
| 11 | 2018 | 50 | |
| 12 | 2015 | 36 | |
| 13 | 2015 | 35 | |
| 14 | 2020 | 33 | |
| 15 | 2021 | 32 | |
| 16 | As2O3 induces apoptosis in human hepatocellular carcinoma HepG2 cells through a ROS-mediated mitochondrial pathway and activation of caspases. | 2015 | 31 |
| 17 | 2010 | 30 | |
| 18 | 2017 | 30 | |
| 19 | 2016 | 29 | |
| 20 | 2016 | 28 |
About Lin Jiang
Lin Jiang is a scholar working on Molecular Biology, Cancer Research, Surgery, Genetics and Oncology, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), Tissue Engineering and Regenerative Medicine (7 papers), RNA modifications and cancer (7 papers), Circular RNAs in diseases (6 papers), Genetic Associations and Epidemiology (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Congenital heart defects research (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Cancer Research (788 citations), Molecular Biology (1.4k citations), Oncology (235 citations), Toxicology (27 citations) and Surgery (313 citations). Lin Jiang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yingbin Liu, Yunping Hu, Yuliang Feng, Xiangsong Wu, Maolan Li, Honghong Tan, Yang Cao, Xiaojun Yang, Jing Xiao and Juan Feng. Their work appears in journals such as Nucleic Acids Research, Experimental Biology and Medicine, Cell Death and Disease, Cancer Cell International and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.